Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Electrolyte Abnormalities Associated With the Use of Atezolizumab - A Systematic Review.

Authors:
Abdul Rafae Sundas Ali Muhammad Khawar Sana Farhan Khalid Rana Ahmed Ibrahim Zahoor Ahmed Ali Jan Hamid Ehsan Tehreem Fatima Arvind Kunadi

J Community Hosp Intern Med Perspect 2022 12;12(2):35-44. Epub 2022 Apr 12.

Department of Internal Medicine, McLaren Flint Michigan State University, Flint, MI, USA.

Background And Objectives: In recent years, immune-checkpoint inhibitors (ICIs) particularly atezolizumab is on the rise in treating advanced malignancies. With its increased clinical use, various electrolyte abnormalities have been reported in the literature. In this review, we have addressed the question of significant electrolyte abnormalities associated with atezolizumab.

Materials And Methods: Following PRISMA guidelines, we performed a thorough literature search in four databases including PubMed, Cochrane Library, Embase, and Clinicaltrials.gov. We included only randomized controlled trials from 2010 till March 2021. After a comprehensive screening of 1587 articles, we selected 14 articles for our review and tabulated the results. Following MeSH terms were used: "electrolyte abnormalities", "immune checkpoint inhibitors", "atezolizumab".

Results: Non-small cell lung cancer (n = 1270) and metastatic urothelial carcinoma (n = 1164) were the most common malignancies among 3160 patients. The most common electrolyte abnormality was hypomagnesemia (4.7%). Hyponatremia, hypophosphatemia, hypercalcemia and hypokalemia were found in 2.3%, 0.63%, 0.25% and 0.06% patients respectively. For patients taking atezolizumab, hypomagnesemia was most frequently found in non-small cell lung carcinoma patients (9.4%), while urothelial metastatic carcinoma patients most commonly had hyponatremia (5.15%). Hypokalemia though insignificant was observed only in patients with metastatic renal cell carcinoma (2.85%).

Conclusion: Since the use of atezolizumab is on the rise for the treatment of various cancers, more studies need to be conducted to better understand its safety and toxicity profile.

Download full-text PDF

Source
http://dx.doi.org/10.55729/2000-9666.1037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195059PMC
April 2022

Publication Analysis

Top Keywords

electrolyte abnormalities
12
non-small cell
8
atezolizumab rise
8
abnormalities associated
8
carcinoma patients
8
cell lung
8
patients
6
carcinoma
4
lung cancer
4
cancer 1270
4
1270 metastatic
4
metastatic urothelial
4
electrolyte
4
urothelial carcinoma
4
carcinoma 1164
4
common malignancies
4
malignancies 3160
4
3160 patients
4
patients common
4
common electrolyte
4

Keyword Occurance

Similar Publications

Effect of Electrolyte Imbalance on Mortality and Late Acute Kidney Injury in Hospitalized COVID-19 Patients.

Authors:
Tahereh Sabaghian Mohamadjavad Honarvar Seyed Amir Ahmad Safavi-Naini Arefe Sadat Sadeghi Fadaki Mohamad Amin Pourhoseingholi Hamidreza Hatamabadi

Iran J Kidney Dis 2022 Jul;16(4):228-237

Safety Promotion and Injury Prevention Research Center, Imam Hossein Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran.

Introduction: As a multisystem illness, Coronavirus disease 2019 (COVID-19) can damage different organs. This study investigated the effect of electrolyte imbalance (EI), with or without concomitant renal dysfunction, on the prognosis of COVID-19 in hospitalized patients.

Methods: We evaluated 499 hospitalized patients with confirmed COVID-19, without a history of chronic kidney disease. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Hyponatremia and SARS-CoV-2 infection: A narrative review.

Authors:
Elmukhtar Habas Elrazi Ali Aml Habas Amnna Rayani Hafedh Ghazouani Fahmi Khan Khalifa Farfar Abdel-Nasser Elzouki

Medicine (Baltimore) 2022 Aug;101(32):e30061

Internal Medicine, Hamad Medical Corporation, Doha, Qatar.

A novel rapid spreading and changing virus called SARS-CoV-2 appeared in Wuhan city in December 2019. It was announced by the World Health Organization (WHO) as a pandemic disease in March 2020. It commonly presents with respiratory symptoms; however, it may be asymptomatic. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Delayed appearance of refeeding syndrome in a patient with anorexia nervosa: A case report.

Authors:
Marta Iacopelli Emanuele Cereda Riccardo Caccialanza Renato Borgatti Martina Maria Mensi

Nutrition 2022 Jul 1;103-104:111788. Epub 2022 Jul 1.

Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy; Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.

Refeeding syndrome (RFS) can be a severe and life-threatening complication of anorexia nervosa (AN) associated with electrolyte abnormalities and organ damage, and occurs with the transition from a prolonged catabolic to anabolic state, particularly with an overzealous nutrient supply. There is no unequivocal definition of RFS, although hypophosphatemia is recognized as a crucial factor in its pathogenesis. RFS can be responsible for cardiovascular complications, such as heart failure, left ventricular damage, and arrhythmias, because of different potential mechanisms: electrolyte imbalances, increased retention of sodium and liquids secondary to insulin secretion, and excessive fat emulsion supplementation. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

The Ominous Triad of Severe Takotsubo Cardiomyopathy.

Authors:
Abdalaziz Awadelkarim Ahmed S Yassin Mohammed Ali John Dayco Eltaib Saad Isra Idris Rashid Alhusain Joseph Sebastian Luis Afonso

J Med Cases 2022 Jul 20;13(7):341-348. Epub 2022 Jul 20.

Department of Cardiology, Wayne State University/Detroit Medical Center, Detroit, MI, USA.

QT prolongation is present in 26-52% of cases of Takotsubo cardiomyopathy (TCM). It has been postulated to result from reduced cardiac repolarization reserve and reflects the transient myocardial insult observed in TCM. Bradycardia-induced QT interval prolongation is amplified by the occurrence of TCM, a combination that potentially carries a significant risk for torsade de pointes (TdP). Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial.

Authors:
Dae Hyun Kim Curtis Tatsuoka Zhengyi Chen Jackson T Wright Michelle C Odden Srinivasan Beddhu Brandon K Bellows Adam Bress Thaddeus Carson William C Cushman Karen C Johnson Donald E Morisky Henry Punzi Leonardo Tamariz Song Yang Lee-Jen Wei

J Gen Intern Med 2022 Aug 9. Epub 2022 Aug 9.

Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.

Background: Communication of the benefits and harms of blood pressure lowering strategy is crucial for shared decision-making.

Objectives: To quantify the effect of intensive versus standard systolic blood pressure lowering in terms of the number of event-free days DESIGN: Post hoc analysis of the Systolic Blood Pressure Intervention Trial PARTICIPANTS: A total of 9361 adults 50 years or older without diabetes or stroke who had a systolic blood pressure of 130-180 mmHg and elevated cardiovascular risk INTERVENTIONS: Intensive (systolic blood pressure goal <120 mmHg) versus standard blood pressure lowering (<140 mmHg) MAIN MEASURES: Days free of major adverse cardiovascular events (MACE), serious adverse events (SAE), and monitored adverse events (hypotension, syncope, bradycardia, electrolyte abnormalities, injurious falls, or acute kidney injury) over a median follow-up of 3.33 years KEY RESULTS: The intensive treatment group gained 14. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap